To further elucidate the functional role of PKC-θ and ZEB1 in CD8+ T cells, we inhibited nPKC-θ with nPKC-θi2 in CD8+ T cells isolated from immunotherapy-responsive (CR/PR) or resistant (PD) melanoma patients. This evidence concerns the gene PRRT2 and melanoma.